Levocarnitine supports fat oxidation, but its not a weight-loss drug
doi: 10.3390/ijms19113306 16 KullmannSHeniMHallschmidMFritscheAPreisslHHringHU
In real life, the most powerful move is improving food quality, protein intake, digestion, sleep, and stress load
GLP-1 receptor agonists in patients with type 2 diabetes and non-alcoholic fatty liver disease
Micronized progesterone, which more closely mirrors the molecular structure of the body's own progesterone, has largely replaced the older synthetic progestins used in the original WHI trial, and appears to offer improved tolerability and a more favorable safety profile [11,27]